Literature DB >> 35362492

Identification of 11β-HSD1 inhibitors through enhanced sampling methods.

Rahul Singh1,2,3, Vijay Kumar Bhardwaj1,2,3, Pralay Das2,3,4, Rituraj Purohit1,2,3.   

Abstract

Aminoarylbenzosuberene (AAB) molecules were chosen for in silico analysis to develop effective and more competent 11β-hydroxysteroid dehydrogenase (11β-HSD1) protein inhibitors. The AAB4 molecule was shown to have stronger interactions and binding affinity than standard inhibitors (co-crystallized molecules). These results were based on conventional, steered and enhanced umbrella sampling simulations.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35362492     DOI: 10.1039/d1cc06894f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  6 in total

1.  Anti-Inflammatory Mechanisms of Total Flavonoids from Mosla scabra against Influenza A Virus-Induced Pneumonia by Integrating Network Pharmacology and Experimental Verification.

Authors:  Wei Cai; Shui-Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

2.  Synthesis, Biological Evaluation, and In Silico Studies of Novel Coumarin-Based 4H,5H-pyrano[3,2-c]chromenes as Potent β-Glucuronidase and Carbonic Anhydrase Inhibitors.

Authors:  Nadia Arif; Zahid Shafiq; Khalid Mahmood; Muhammad Rafiq; Sadia Naz; Sohail Anjum Shahzad; Umar Farooq; Ali H Bahkali; Abdallah M Elgorban; Muhammad Yaqub; Ahmed El-Gokha
Journal:  ACS Omega       Date:  2022-08-04

3.  Comprehensive Network Analysis Reveals the Targets and Potential Multitarget Drugs of Type 2 Diabetes Mellitus.

Authors:  Wan Zhou; Qiang Liu; Wei Wang; Xiao-Jing Yuan; Chun-Chun Xiao; Shan-Dong Ye
Journal:  Oxid Med Cell Longev       Date:  2022-07-28       Impact factor: 7.310

4.  Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis.

Authors:  Bin Yu; Maoru Wang; Hui Xu; Rongrong Gao; Yuanying Zhu; Hong Ning; Xiaoyu Dai
Journal:  Biomed Res Int       Date:  2022-07-15       Impact factor: 3.246

5.  Therapeutic Mechanism and Key Active Ingredients of Shenfu Injection in Sepsis: A Network Pharmacology and Molecular Docking Approach.

Authors:  Huajing Yuan; Yang Liu; Kai Huang; Hao Hao; Yi-Tao Xue
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-26       Impact factor: 2.650

6.  Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis.

Authors:  Guibin Liang; Jiuang Li; Shiqian Pu; Zhihui He
Journal:  J Healthc Eng       Date:  2022-09-26       Impact factor: 3.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.